These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1386752)

  • 21. [Prevention of hepatitis B by vaccination in 53 children at risk. Transmission of hepatitis B virus infection and its prevention].
    Zecca G; Motti G; Manzoni C; Del Curto E
    Minerva Pediatr; 1985 Sep; 37(17):593-6. PubMed ID: 2934613
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
    Schalm SW; Mazel JA; de Gast GC; Heijtink RA; Botman MJ; Bänffer JR; Cerards LJ; Zwijnenberg J; Fetter WP; Nuijten SM
    Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yeast recombinant hepatitis B vaccine in perinatal hepatitis B virus transmission: a preliminary report.
    Stevens CE; Taylor PE; Tong MJ; Toy PT; Vyas GN
    J Infect; 1986 Jul; 13 Suppl A():13. PubMed ID: 2943810
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?
    Powis JE; Raboud J; Ostrowski M; Loutfy MR; Kovacs C; Walmsley SL
    J Infect Dis; 2012 May; 205(10):1534-8. PubMed ID: 22448009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Seroconversion following immunization with a plasma-derived vaccine against hepatitis B: study of a 3-injection protocol (0, 1, 6 months) in Brazzaville (Congo)].
    Taty-Taty R; Saliou P; Yala F; Couroucé AM; Arthaud ML; Nerelli B; Biendo M; Wassoumbou E
    Bull Soc Pathol Exot; 1990; 83(2):155-8. PubMed ID: 2145083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis vaccination of adults].
    Jost R
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of accidental hepatitis B virus infection in hemodialysis staff members: comparison with immune globulin without vaccine in historical controls.
    Mitsui T; Iwano K; Suzuki S; Yamazaki C; Masuko K; Tsuda F; Aihara S; Akahane Y; Miyakawa Y; Mayumi M
    Hepatology; 1989 Sep; 10(3):324-7. PubMed ID: 2527191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state.
    Tada H; Yanagida M; Mishina J; Fujii T; Baba K; Ishikawa S; Aihara S; Tsuda F; Miyakawa Y; Mayumi M
    Pediatrics; 1982 Oct; 70(4):613-9. PubMed ID: 7122162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
    Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
    Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vaccination against hepatitis virus B infection. Vaccine from inactivated HBsAg positive plasma or recombinant vaccine?].
    Horejsí J
    Cas Lek Cesk; 1987 Jul; 126(31):981-2. PubMed ID: 2959363
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful kidney transplantation from a hepatitis B surface antigen-positive donor to an antigen-negative recipient using a novel vaccination regimen.
    Singh G; Hsia-Lin A; Skiest D; Germain M; O'Shea M; Braden G
    Am J Kidney Dis; 2013 Apr; 61(4):608-11. PubMed ID: 23219109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis B in pregnancy: clinical and prophylactic implications].
    Figueroa Damián R; Sánchez Fernández L; Benavides Covarrubias E
    Ginecol Obstet Mex; 1995 Feb; 63():90-5. PubMed ID: 7698681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of hepatitis B virus infection.
    Akahane Y; Tsuda F; Mayumi M
    Hepatology; 1989 Sep; 10(3):398. PubMed ID: 2527193
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of hepatocellular carcinoma by immunization against hepatitis B.
    Zuckerman AJ
    Int Rev Exp Pathol; 1985; 27():59-81. PubMed ID: 3017884
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatitis B virus vaccination in the province of Saragossa].
    Arribas Monzón FE; Abad Díez JM; Amorín Calzada MJ; Barrasa Villar I; Aibar Remón C; García Mata JR; Gómez López LI
    Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):629-34. PubMed ID: 2151507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 40. [Combined passive and active immunization for preventing the development of the infantile carrier state in hepatitis B virus vertical transmission].
    Ijichi M; Inaba N; Takamizawa H; Ohkawa R
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Feb; 39(2):263-70. PubMed ID: 3819521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.